Search results
Results from the WOW.Com Content Network
The Breast Cancer Risk Assessment Tool (BCRAT) is an online calculator designed to predict a woman’s risk of developing invasive breast cancer in both the short term, within five years, and ...
A number of different tools exist, but the two most commonly used ones are the Breast Cancer Risk Assessment Tool (BCRAT, formerly called the “Gail Model”) and the International Breast Cancer ...
The Breast Cancer Risk Assessment Tool (BCRAT), also known as the Gail Model, is one of the most common and popular tests used to identify those women at risk for breast cancer, says Sherry Ross ...
In PRES related to medications, there may be an interval of weeks to months between the initiation of the treatment and the development of PRES. [1] [3] After a hematopoietic stem cell transplantation (bone marrow transplant) the risk of PRES is approximately 8%, whereas the risk is lower (0.4-6%) after a solid organ transplant. [3]
The site began in 1998 as a pen and paper questionnaire called the Harvard Cancer Risk Index. [2] In January 2000, The Harvard Cancer Risk Index developed into an online assessment and was renamed Your Cancer Risk, and offered assessments for four cancers: breast, colon, lung, and prostate. Six months later, eight additional cancers were added. [3]
In scans where women receive 0.25–20 Gray (Gy) of radiation, they have more of an elevated risk of developing breast cancer. [40] A study of radiation risk from mammography concluded that for women 40 years of age and older, the risk of radiation-induced breast cancer was minuscule, particularly compared with the potential benefit of ...
Munn credited her OB/GYN and “guardian angel” with saving her life by recommending the Breast Cancer Risk Assessment Tool (BCRAT). Olivia Munn was diagnosed with breast cancer 2 months after a ...
Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.